Free Trial
NASDAQ:DRIO

DarioHealth (DRIO) Stock Price, News & Analysis

DarioHealth logo
$0.96
-0.04 (-4.00%)
(As of 10/31/2024 ET)

About DarioHealth Stock (NASDAQ:DRIO)

Key Stats

Today's Range
$0.95
$1.00
50-Day Range
$0.78
$1.13
52-Week Range
$0.68
$2.60
Volume
27,236 shs
Average Volume
113,736 shs
Market Capitalization
$28.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
58th Percentile Overall Score

DRIO MarketRank™: 

DarioHealth scored higher than 58% of companies evaluated by MarketBeat, and ranked 521st out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DarioHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    DarioHealth has received no research coverage in the past 90 days.

  • Read more about DarioHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for DarioHealth are expected to grow in the coming year, from ($1.21) to ($1.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DarioHealth is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DarioHealth is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DarioHealth has a P/B Ratio of 0.45. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DarioHealth's valuation and earnings.
  • Percentage of Shares Shorted

    5.88% of the outstanding shares of DarioHealth have been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 18.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently decreased by 0.56%, indicating that investor sentiment is improving.
  • Dividend Yield

    DarioHealth does not currently pay a dividend.

  • Dividend Growth

    DarioHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.88% of the outstanding shares of DarioHealth have been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 18.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently decreased by 0.56%, indicating that investor sentiment is improving.
  • News Sentiment

    DarioHealth has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for DarioHealth this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, DarioHealth insiders have bought more of their company's stock than they have sold. Specifically, they have bought $16,500.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    15.70% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 33.39% of the stock of DarioHealth is held by institutions.

  • Read more about DarioHealth's insider trading history.
Receive DRIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

DRIO Stock News Headlines

DarioHealth signs new regional health plan
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Twill by Dario to Offer a Benefit for AARP Members
See More Headlines

DRIO Stock Analysis - Frequently Asked Questions

DarioHealth's stock was trading at $1.72 at the start of the year. Since then, DRIO shares have decreased by 44.2% and is now trading at $0.9601.
View the best growth stocks for 2024 here
.

DarioHealth Corp. (NASDAQ:DRIO) announced its quarterly earnings results on Thursday, August, 8th. The company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.51) by $0.43. The firm had revenue of $6.26 million for the quarter, compared to analysts' expectations of $7.57 million. DarioHealth had a negative net margin of 265.33% and a negative trailing twelve-month return on equity of 74.64%.

DarioHealth subsidiaries include PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc..

Top institutional shareholders of DarioHealth include DLK Investment Management LLC (0.34%) and Clarity Capital Partners LLC (0.09%). Insiders that own company stock include Erez Raphael, Steven Charles Nelson and Dror Bacher.
View institutional ownership trends
.

Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include Palantir Technologies (PLTR), NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA).

Company Calendar

Last Earnings
8/08/2024
Today
10/31/2024
Next Earnings (Confirmed)
11/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DRIO
Employees
200
Year Founded
2011

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+316.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-59,430,000.00
Net Margins
-265.33%
Pretax Margin
-275.41%

Debt

Sales & Book Value

Annual Sales
$19.15 million
Book Value
$2.14 per share

Miscellaneous

Free Float
25,314,000
Market Cap
$28.73 million
Optionable
Optionable
Beta
1.48

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:DRIO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners